Eiry Roberts - Net Worth and Insider Trading
Eiry Roberts Net Worth
The estimated net worth of Eiry Roberts is at least $5 Million dollars as of 2025-07-23. Eiry Roberts is the Chief Medical Officer of Neurocrine Biosciences Inc and owns about 35,640 shares of Neurocrine Biosciences Inc (NBIX) stock worth over $5 Million. Details can be seen in Eiry Roberts's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eiry Roberts has not made any transactions after 2025-02-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Eiry Roberts
Eiry Roberts Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eiry Roberts owns 2 companies in total, including Neurocrine Biosciences Inc (NBIX) , and Amicus Therapeutics Inc (FOLD) .
Click here to see the complete history of Eiry Roberts’s form 4 insider trades.
Insider Ownership Summary of Eiry Roberts
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| NBIX | Neurocrine Biosciences Inc | 2025-02-14 | Chief Medical Officer |
| FOLD | Amicus Therapeutics Inc | 2021-06-10 | director |
Eiry Roberts Latest Holdings Summary
Eiry Roberts currently owns a total of 1 stock. Eiry Roberts owns 35,640 shares of Neurocrine Biosciences Inc (NBIX) as of February 14, 2025, with a value of $5 Million.
Latest Holdings of Eiry Roberts
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NBIX | Neurocrine Biosciences Inc | 2025-02-14 | 35,640 | 132.75 | 4,731,210 |
Holding Weightings of Eiry Roberts
Eiry Roberts Form 4 Trading Tracker
According to the SEC Form 4 filings, Eiry Roberts has made a total of 20 transactions in Neurocrine Biosciences Inc (NBIX) over the past 5 years, including 0 buys and 20 sells. The most-recent trade in Neurocrine Biosciences Inc is the sale of 2,218 shares on February 14, 2025, which brought Eiry Roberts around $258,264.
Insider Trading History of Eiry Roberts
- 1
Eiry Roberts Trading Performance
Eiry Roberts Ownership Network
Ownership Network List of Eiry Roberts
Ownership Network Relation of Eiry Roberts
Eiry Roberts Owned Company Details
What does Neurocrine Biosciences Inc do?
Who are the key executives at Neurocrine Biosciences Inc?
Eiry Roberts is the Chief Medical Officer of Neurocrine Biosciences Inc. Other key executives at Neurocrine Biosciences Inc include Chief Regulatory Officer Ingrid Delaet , Chief Scientific Officer Jude Onyia , and Sr VP & Business Development Kevin Charles Gorman .
Neurocrine Biosciences Inc (NBIX) Insider Trades Summary
Over the past 18 months, Eiry Roberts made 6 insider transaction in Neurocrine Biosciences Inc (NBIX) with a net sale of 9,327. Other recent insider transactions involving Neurocrine Biosciences Inc (NBIX) include a net sale of 34,005 shares made by Ingrid Delaet , a net sale of 178,724 shares made by Eric Benevich , and a net sale of 54,716 shares made by Matt Abernethy .
In summary, during the past 3 months, insiders sold 120,251 shares of Neurocrine Biosciences Inc (NBIX) in total and bought 0 shares, with a net sale of 120,251 shares. During the past 18 months, 897,472 shares of Neurocrine Biosciences Inc (NBIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 897,472 shares.
Neurocrine Biosciences Inc (NBIX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Neurocrine Biosciences Inc Insider Transactions
Eiry Roberts Mailing Address
Above is the net worth, insider trading, and ownership report for Eiry Roberts. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Eiry Roberts's mailing address is: San Dieo Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
